Answers are grounded in this paper and cite their sources.
BACKGROUND: Canine mast cell tumours (MCTs) frequently metastasise to regional lymph nodes (LNs), including those that appear clinically normal. METHODS: This retrospective single-institution case series included 50 dogs with cutaneous or subcutaneous MCTs treated between 2021 and 2023. Tumours and clinically normal regional LNs were surgically excised and histologically evaluated. Associations between clinicopathological variables and LN metastasis were explored at the patient level. RESULTS: Eighty-three MCTs, including 69 cutaneous and 14 subcutaneous tumours, and 78 regional LNs were evaluated. Among cutaneous MCTs, 62 of 69 (89.9%) were Kiupel low grade and seven of 69 (10.1%) were high grade. The subcutaneous tumours comprised six infiltrative, six circumscribed and two combined growth patterns. Histological examination classified 31 of 78 LNs (39.7%) as HN0, 19 of 78 (24.4%) as HN1, 20 of 78 (25.6%) as HN2 and eight of 78 (10.3%) as HN3. Overall, 23 of 50 dogs (46.0%) had at least one metastatic LN. LN metastasis was associated with a maximum tumour diameter of more than 3 cm (p = 0.045) and Kiupel high grade (p = 0.007). LIMITATIONS: Limitations included the retrospective single-institution design, small sample size, sparse observations in some categories, and unavailable information on serial LN sectioning. CONCLUSION: Histologically confirmed metastasis was frequently identified in clinically normal regional LNs, supporting the value of histological evaluation of regional LNs for accurate clinical staging.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: